B. D. Agnis, D. S. Berman, D. Spicehandler, W. El-sadr, M. S. Simberkoff et al., Effect of Combined Therapy with Ansamycin, Clofazimine, Ethambutol, and Isoniazid for Mycobacterium avium Infection in Patients with AIDS, Journal of Infectious Diseases, vol.159, issue.4, pp.784-787, 1989.
DOI : 10.1093/infdis/159.4.784

E. J. Baron and L. S. Young, Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome, Diagnostic Microbiology and Infectious Disease, vol.5, issue.3, pp.215-220, 1986.
DOI : 10.1016/0732-8893(86)90004-0

C. A. Benson and J. J. Ellner, Mycobacterium avium Complex Infection and AIDS: Advances in Theory and Practice, Clinical Infectious Diseases, vol.17, issue.1, pp.7-20, 1993.
DOI : 10.1093/clinids/17.1.7

A. Bryskier, C. Agouridas, and J. C. Gasc, Classification of macrolide antibiotics, Macrolides: chemistry, pharmacology and clinical uses, pp.5-66, 1993.

S. C. Edberg and L. S. Sabath, Determination of antibiotic levels in body fluids: techniques and significance. Bacterial tests in endocarditis and other severe infections Antibiotics in laboratory medicine, pp.206-264, 1980.

C. G. Gemmell, Macrolides and host defences to respiratory tract pathogens, Journal of Hospital Infection, vol.19, pp.11-19, 1991.
DOI : 10.1016/0195-6701(91)90213-R

S. M. Gordon, C. R. Horsburg, J. , C. A. Peloquin, J. A. Havlik et al., Low Serum Levels of Oral Antimycobacterial Agents in Patients with Disseminated Mycobacterium avium Complex Disease, Journal of Infectious Diseases, vol.168, issue.6, pp.1559-1562, 1993.
DOI : 10.1093/infdis/168.6.1559

H. A. Kirst and G. D. Sides, New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy., Antimicrobial Agents and Chemotherapy, vol.33, issue.9, pp.1419-1422, 1989.
DOI : 10.1128/AAC.33.9.1419

L. Levy, Pharmacological studies with clofazimine (B663) in man, Am. J. Trop. Med. Hyg, vol.23, pp.1116-1121, 1974.

H. Masur, Recommendations on Prophylaxis and Therapy for Disseminated Mycobacterium avium Complex Disease in Patients Infected with the Human Immunodeficiency Virus, New England Journal of Medicine, vol.329, issue.12, pp.898-904
DOI : 10.1056/NEJM199309163291228

J. K. Mcclatchy, Antituberculous drugs: mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biological fluids Antibiotics in laboratory medicine, pp.135-169, 1980.

N. Rastogi, Mycobacteria as intracellular pathogens: current notions of pathogenicity, virulence, and drug resistance and their relation to effective therapy Antimicrobial agents and intracellular pathogens, pp.245-300, 1993.

J. T. Ellner, P. J. Belisle, and . Brennan, 11th Forum in microbiology; laboratory and clinical aspects of the Mycobacterium avium epidemic: contributing factors associated with variability of drug susceptibility and immune responsiveness, and the multifaceted nature of pathogenicity, Res. Microbiol, vol.145, pp.167-261, 1994.

N. Rastogi, C. Fréhel, A. Ryter, H. Ohayon, M. Lesourd et al., Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?, Antimicrobial Agents and Chemotherapy, vol.20, issue.5, pp.666-677, 1981.
DOI : 10.1128/AAC.20.5.666

N. Rastogi, K. S. Goh, and A. Bryskier, In vitro activity of roxithromycin against 16 species of atypical mycobacteria and effect of pH on its radiometric MICs., Antimicrobial Agents and Chemotherapy, vol.37, issue.7, pp.1560-1562, 1993.
DOI : 10.1128/AAC.37.7.1560

URL : https://hal.archives-ouvertes.fr/pasteur-00925365

N. Rastogi, K. S. Goh, and A. Bryskier, Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex., Antimicrobial Agents and Chemotherapy, vol.38, issue.6, pp.1433-1438, 1994.
DOI : 10.1128/AAC.38.6.1433

URL : https://hal.archives-ouvertes.fr/pasteur-00925370